220 related articles for article (PubMed ID: 11896119)
61. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.
Ruggiero A; De Rosa G; Rizzo D; Leo A; Maurizi P; De Nisco A; Vendittelli F; Zuppi C; Mordente A; Riccardi R
Int J Clin Oncol; 2013 Oct; 18(5):927-33. PubMed ID: 22911020
[TBL] [Abstract][Full Text] [Related]
62. [Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(3-4):164-73. PubMed ID: 12182001
[TBL] [Abstract][Full Text] [Related]
63. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.
Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; McIntosh K; Schluchter MD; Colan SD
Circulation; 1998 Apr; 97(13):1246-56. PubMed ID: 9570194
[TBL] [Abstract][Full Text] [Related]
64. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
65. Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.
Shapiro CL; Ervin T; Welles L; Azarnia N; Keating J; Hayes DF
J Clin Oncol; 1999 May; 17(5):1435-41. PubMed ID: 10334528
[TBL] [Abstract][Full Text] [Related]
66. Peak plasma concentrations of doxorubicin in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
Hempel G; Flege S; Würthwein G; Boos J
Cancer Chemother Pharmacol; 2002 Feb; 49(2):133-41. PubMed ID: 11862427
[TBL] [Abstract][Full Text] [Related]
67. Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.
Fisher SD; Easley KA; Orav EJ; Colan SD; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; Lipshultz SE;
Am Heart J; 2005 Sep; 150(3):439-47. PubMed ID: 16169321
[TBL] [Abstract][Full Text] [Related]
68. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.
Escherich G; Zimmermann M; Janka-Schaub G;
Pediatr Blood Cancer; 2013 Feb; 60(2):254-7. PubMed ID: 22948968
[TBL] [Abstract][Full Text] [Related]
69. [Cardiotoxicity of doxorubicin in children].
Pilon JW; Naeff MS; Taminiau JA
Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
[No Abstract] [Full Text] [Related]
70. [Diagnostic markers of anthracycline-induced cardiomyopathy in children with acute leukemia].
Shatyns'ka TV
Lik Sprava; 2014; (3-4):20-6. PubMed ID: 25286593
[TBL] [Abstract][Full Text] [Related]
71. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
72. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.
Chan S; Friedrichs K; Noel D; Pintér T; Van Belle S; Vorobiof D; Duarte R; Gil Gil M; Bodrogi I; Murray E; Yelle L; von Minckwitz G; Korec S; Simmonds P; Buzzi F; González Mancha R; Richardson G; Walpole E; Ronzoni M; Murawsky M; Alakl M; Riva A; Crown J;
J Clin Oncol; 1999 Aug; 17(8):2341-54. PubMed ID: 10561296
[TBL] [Abstract][Full Text] [Related]
73. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
74. Randomized study comparing 4'-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia.
Bhutani M; Kumar L; Vora A; Bhardwaj N; Pathak AK; Singh R; Kochupillai V
Am J Hematol; 2002 Dec; 71(4):241-7. PubMed ID: 12447951
[TBL] [Abstract][Full Text] [Related]
75. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
76. Developing a rat model of dilated cardiomyopathy with improved survival.
Shen LJ; Lu S; Zhou YH; Li L; Xing QM; Xu YL
J Zhejiang Univ Sci B; 2016 Dec.; 17(12):975-983. PubMed ID: 27921402
[TBL] [Abstract][Full Text] [Related]
77. Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer.
Pihkala J; Sariola H; Saarinen UM
Pediatr Hematol Oncol; 1994; 11(3):259-69. PubMed ID: 8060810
[TBL] [Abstract][Full Text] [Related]
78. Cardiac diastolic function in pediatric patients receiving doxorubicin.
Ewer MS; Ali MK; Gibbs HR; Swafford J; Graff KL; Cangir A; Jaffe N; Thapar MK
Acta Oncol; 1994; 33(6):645-9. PubMed ID: 7946442
[TBL] [Abstract][Full Text] [Related]
79. Low R-wave amplitude in the right precordial leads in children with symptomatic doxorubicin cardiomyopathy.
Umemoto M; Azuma E; Itoh M; Komada Y; Ido M; Kawasaki H; Kita H; Sakurai M
Pediatr Cardiol; 1993 Mar; 14(2):107-9. PubMed ID: 8385775
[TBL] [Abstract][Full Text] [Related]
80. Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.
Sriskandan S; O'Brien ME; Smith IE; Collins P; Gore ME
Postgrad Med J; 1994 Oct; 70(828):759-61. PubMed ID: 7831179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
